We are working to raise the profile of testing and increase diagnostic literacy.

We work with partners on targeted advocacy efforts from global and ministerial to community levels.

We support the development of mutually agreed accountability frameworks, including country action plans, to strengthen commitment to testing and monitor the implementation of diagnostic strategies, and ensure continued assessment of our work. Our stakeholders include advocates, advocacy networks, diagnostics champions, and representatives to political fora such as the G7 and the G20. Our advocacy focus is both disease-specific as well as cross-cutting, covering a range of themes including human rights and gender.

G20 in Goa, India

G20 engagement

Diagnostic priorities at the 2023 health working group discussions in India.

Yes! We can end TB

Every year, millions of people with TB are not diagnosed resulting in millions of preventable deaths. While TB tests exist, they are currently not fit-for-purpose nor available where they are needed the most. If the world is to meet the WHO goal of reducing TB deaths by 90% by 2030, we need simple, rapid tests that work for everyone, everywhere.

SHG (self-help group) member Parvati visits villages to screen household contacts of all previously and currently diagnosed TB patients to coordinate for testing. Photo credit: FIND & MYRADA/Adithya Shankar

FIND position statement: TRIPS waivers

Following the waiver of certain patent-related Articles of the World Trade Organization (WTO) Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS) for COVID-19 vaccines, there have been ongoing discussions around a potential extension of this waiver to cover the production and supply of COVID-19 therapeutics and diagnostics.

World Health Assembly Resolution on diagnostics

We support the recommendation by The Lancet Commission to adopt a WHA Resolution on diagnostics.